Literature DB >> 1351000

Evidence that non-NMDA receptors are involved in the excitatory pathway from the pedunculopontine region to nigrostriatal dopaminergic neurons.

S Di Loreto1, T Florio, E Scarnati.   

Abstract

Extracellular single-neuron recordings were obtained from electrophysiologically identified nigrostriatal neurons in chloral hydrate anesthetized rats, in order to test the hypothesis that excitatory amino acid receptors are involved in responses of these neurons to electrical stimulation of the pontine region where the pedunculopontine nucleus (PPN) is located. The effects of iontophoretic application of excitatory amino acids and their antagonists as well as of cholinergic antagonists were tested on the fast orthodromic excitation of nigrostriatal neurons evoked by stimulation of the PPN region. The N-methyl-D-aspartate (NMDA) receptor antagonist D-alpha-aminoadipic acid as well as the cholinergic receptor antagonists mecamylamine and atropine failed to suppress the synaptic excitation of nigral neurons. The NMDA receptor antagonist DL-2-amino-5-phosphonovalerate exerted a weak depressant action on the synaptic response in a few neurons only. On the contrary, the broad spectrum antagonists of excitatory amino acid receptors kynurenic acid and gamma-D-glutamyl-amino-methyl-sulphonate were found to block simultaneously both the synaptic excitation and the neuronal responses to iontophoretic pulses of glutamate while leaving unaffected the neuronal responses to local application of acetylcholine or carbachol. The competitive antagonist of non-NMDA receptors 6-cyano-2,3-dihydroxy-7-nitro-quinoxaline suppressed the synaptic excitation at ejection currents which antagonized neuronal responses to quisqualate and kainate. These results suggest that PPN excitatory fibers synapsing onto pars compacta nigrostriatal neurons utilize an excitatory amino acid as a synaptic transmitter acting preferentially on non-NMDA receptors.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1351000     DOI: 10.1007/bf00229003

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  48 in total

1.  Immunohistochemical localization of neuronal nicotinic receptors in the rodent central nervous system.

Authors:  L W Swanson; D M Simmons; P J Whiting; J Lindstrom
Journal:  J Neurosci       Date:  1987-10       Impact factor: 6.167

2.  A cholinergic projection to the rat substantia nigra from the pedunculopontine tegmental nucleus.

Authors:  M Beninato; R F Spencer
Journal:  Brain Res       Date:  1987-05-26       Impact factor: 3.252

3.  An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid.

Authors:  M N Perkins; T W Stone
Journal:  Brain Res       Date:  1982-09-09       Impact factor: 3.252

4.  The influence of striatal stimulation and putative neurotransmitters on identified neurones in the rat substantia nigra.

Authors:  G L Collingridge; J Davies
Journal:  Brain Res       Date:  1981-05-18       Impact factor: 3.252

5.  Neuronal loss in the pedunculopontine tegmental nucleus in Parkinson disease and in progressive supranuclear palsy.

Authors:  E C Hirsch; A M Graybiel; C Duyckaerts; F Javoy-Agid
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

6.  Substantia nigra cell death from kainic acid or folic acid injections into the pontine tegmentum.

Authors:  E G McGeer; P L McGeer
Journal:  Brain Res       Date:  1984-04-30       Impact factor: 3.252

7.  Actions of D and L forms of 2-amino-5-phosphonovalerate and 2-amino-4-phosphonobutyrate in the cat spinal cord.

Authors:  J Davies; J C Watkins
Journal:  Brain Res       Date:  1982-03-11       Impact factor: 3.252

8.  Dopamine neurons of the monkey midbrain: contingencies of responses to active touch during self-initiated arm movements.

Authors:  R Romo; W Schultz
Journal:  J Neurophysiol       Date:  1990-03       Impact factor: 2.714

9.  Autoradiographic distribution of high affinity muscarinic and nicotinic cholinergic receptors labeled with [3H]acetylcholine in rat brain.

Authors:  R D Schwartz
Journal:  Life Sci       Date:  1986-06-09       Impact factor: 5.037

10.  Muscarinic receptors in the central nervous system of the rat. II. Distribution of binding of [3H]propylbenzilylcholine mustard in the midbrain and hindbrain.

Authors:  A Rotter; N J Birdsall; P M Field; G Raisman
Journal:  Brain Res       Date:  1979       Impact factor: 3.252

View more
  9 in total

1.  Distinct roles for nigral GABA and glutamate receptors in the regulation of dendritic dopamine release under normal conditions and in response to systemic haloperidol.

Authors:  William S Cobb; Elizabeth D Abercrombie
Journal:  J Neurosci       Date:  2002-02-15       Impact factor: 6.167

2.  AMPA and NMDA glutamate receptor subunits in midbrain dopaminergic neurons in the squirrel monkey: an immunohistochemical and in situ hybridization study.

Authors:  M Paquet; M Tremblay; J J Soghomonian; Y Smith
Journal:  J Neurosci       Date:  1997-02-15       Impact factor: 6.167

3.  Behavioral and neurotransmitter specific roles for the ventral tegmental area in reinforcer-seeking and intake.

Authors:  Cristine L Czachowski; Michael J Delory; Jason D Pope
Journal:  Alcohol Clin Exp Res       Date:  2012-03-20       Impact factor: 3.455

Review 4.  Ethanol action on dopaminergic neurons in the ventral tegmental area: interaction with intrinsic ion channels and neurotransmitter inputs.

Authors:  Hitoshi Morikawa; Richard A Morrisett
Journal:  Int Rev Neurobiol       Date:  2010       Impact factor: 3.230

Review 5.  The pedunclopontine nucleus and Parkinson's disease.

Authors:  Cecilia Tubert; Daniel Galtieri; D James Surmeier
Journal:  Neurobiol Dis       Date:  2018-08-29       Impact factor: 5.996

6.  The striatal dopaminergic catalepsy mechanism is not necessary for the expression of pontine catalepsy produced by carbachol injections into the pontine reticular formation.

Authors:  Z Elazar; N Peleg; M Paz; G Ring
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-08       Impact factor: 3.000

Review 7.  Therapeutic potential of targeting group III metabotropic glutamate receptors in the treatment of Parkinson's disease.

Authors:  Susan Duty
Journal:  Br J Pharmacol       Date:  2010-09       Impact factor: 8.739

Review 8.  Neuronal Reward and Decision Signals: From Theories to Data.

Authors:  Wolfram Schultz
Journal:  Physiol Rev       Date:  2015-07       Impact factor: 37.312

Review 9.  Reward functions of the basal ganglia.

Authors:  Wolfram Schultz
Journal:  J Neural Transm (Vienna)       Date:  2016-02-02       Impact factor: 3.575

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.